Skip to content

DuPont seeks pesticide buyer to 'create strong competitor'

Don't let 'media reports become a distraction,' says CEO Breen

Here's the text of yesterday's "Inside the Oval," a DuPont internal newsletter, from CEO Edward Breen to employees, on plans to spin off "a portion" of the company's pesticide business, with "associated R&D," and sell it to "a single buyer" so as to keep markets competitive and win European approval for the Dow merger:

DuPont Colleagues:
I want to provide an update on the regulatory review of our proposed merger with Dow.

We have submitted a remedy package to the European Commission (EC), and as a result the EC today [2/8] extended its deadline for reviewing the merger to April 4. [DATE CORRECTED. Joe D.]

We believe the proposed remedies we offered address the EC's concerns, while maintaining the strategic logic and value creation potential of the transaction for all stake holders.

While we cannot disclose the specific details of the remedies, we can share that they include the proposed divestment of a portion of DuPont's crop protection business and associated R&D to a single buyer to create a strong crop protection industry competitor.

They also include Dow's acid copolymers and isomers business. [See for example DuPont's Nucrel aluminum juice, tea-bag and electric-cable sealant business here]

Regardless of the final form of the remedy package, it is important to emphasize that we are committed to ensuring we maintain — and enhance — the potential of all our businesses for the benefit of all stakeholders, including our valued employees.

We continue to work constructively with regulators in all relevant jurisdictions to obtain clearance for the merger, which we are confident will be achieved.

As we move forward in our discussions with the EC and other regulators, we expect there will be speculative media reports about the remedies. We encourage you not to let these media reports become a distraction.

As you already have demonstrated, maintaining focus on our Core Values and on our customers, and providing support for one another, are critical priorities.

I recognize — and am grateful — that our team at DuPont has continued to serve our customers during this period. I ask you to continue keeping up that great focus and delivering continued strong results.

We continue to expect to close the merger in the first half of 2017, and will provide further updates on the regulatory process as soon as we can. 

Thank you for all that you do on behalf of DuPont. 
Ed Breen
Chair & CEO Ed Breen

More in my previous item here.